ACHE and Alzheimer disease: Thus, new cholinesterase inhibitors, in addition to their potential clinical importance if followed by proper pharmacological investigations, would help in defining the role of BChE in brain development, health, and ageing and would in the meantime reveal the value of both BChE and AChE inhibition as a novel strategy for the treatment of AD.